DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,724,956 | -7.2% | 7,457 | -0.5% | 1.30% | -20.8% |
| Q3 2023 | $1,859,382 | +4.7% | 7,494 | +1.3% | 1.64% | +12.8% |
| Q2 2023 | $1,775,266 | +116.6% | 7,397 | +124.7% | 1.45% | +93.1% |
| Q1 2023 | $819,621 | +8.1% | 3,292 | +15.2% | 0.75% | -1.1% |
| Q4 2022 | $758,542 | -16.0% | 2,858 | -18.2% | 0.76% | -23.9% |
| Q3 2022 | $903,000 | +0.7% | 3,496 | -1.2% | 1.00% | +8.7% |
| Q2 2022 | $897,000 | -13.4% | 3,539 | +0.2% | 0.92% | +9.0% |
| Q1 2022 | $1,036,000 | -34.2% | 3,532 | -26.2% | 0.84% | -22.6% |
| Q4 2021 | $1,575,000 | +0.9% | 4,787 | -5.0% | 1.09% | -4.3% |
| Q3 2021 | $1,561,000 | -9.9% | 5,041 | -18.9% | 1.14% | -16.3% |
| Q2 2021 | $1,732,000 | +12.0% | 6,214 | -9.5% | 1.36% | -4.3% |
| Q1 2021 | $1,546,000 | +0.7% | 6,869 | -0.6% | 1.42% | -7.3% |
| Q4 2020 | $1,535,000 | – | 6,908 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |